3 Patents
- US125595632026Müllerian Inhibiting Substance Type 2 Receptor (misiir)-specific CAR T Cells for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies
The Trustees Of The University Of Pennsylvania
0 cites - US122275882025Use of CD2/5/7 Knock-out Anti-cd2/5/7 Chimeric Antigen Receptor T Cells Against T Cell Lymphomas and Leukemias
The Trustees Of The University Of Pennsylvania
0 cites - US116739642023Use of CD2/5/7 Knock-out Anti-cd2/5/7 Chimeric Antigen Receptor T Cells Against T Cell Lymphomas and Leukemias
The Trustees Of The University Of Pennsylvania
0 cites